Browsing by Author Varea, Sara
Showing results 1 to 4 of 4
| Issue Date | Title | Author(s) |
|---|---|---|
| 1-Dec-2021 | Factors associated with the clinical outcome of patients with relapsed/refractory CD19+acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy | Ortiz-Maldonado Gibson, Valentín; Rives, Susana; Español Rego, Marta; Alonso Saladrigues, A.; Montoro, Mercedes; Magnano, Laura; Giné Soca, Eva; Pascal i Capdevila, Mariona; Díaz Beyà, Marina; Castella, Maria; Català, Albert; Faura, Anna; Rodríguez Lobato, Luis Gerardo; Oliver Caldés, Aina; Martínez Roca, Alexandra; Rovira, Montserrat; González Navarro, Europa Azucena; Ortega, Juan Ramón; Cid Vidal, Joan; Lozano, Miquel; García Rey, Enric; Fernández, Sara; Castro Rebollo, Pedro; Jordán García, Iolanda; Villamor i Casas, Neus; Aymerich Gregorio, Marta; Torrebadell, Montserrat; Deyá, Angela; Fernández de Larrea Rodríguez, Carlos José; Benítez-Ribas, Daniel; Trias, Esteve; Varea, Sara; Calvo Rojas, Gonzalo; Esteve, Jordi; Urbano Ispizua, Álvaro; Juan, Manel; Delgado, Julio (Delgado González) |
| 1-Jul-2023 | Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CART-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA- HCB-01): a single-arm, multicentre, academic pilot study | Oliver Caldés, Aina; González Calle, Verónica; Cabañas, Valentín; Español Rego, Marta; Rodríguez Otero, Paula; Reguera, Juan Luis; López Corral, Lucía; Martin Antonio, Beatriz; Zabaleta, Aintzane; Inogés, Susana; Varea, Sara; Rosiñol, Laura; López-Díaz de Cerio, Ascensión; Tovar, Natalia; Jiménez, Raquel; López Parra, Miriam; Rodríguez Lobato, Luis Gerardo; Sánchez Salinas, Andrés; Olesti, Eulàlia; Calvo Orteu, Maria; Delgado, Julio; Pérez Simón, José Antonio; Paiva, Bruno; Prósper, Felipe; Sáez Peñataro, Joaquín; Juan, Manel E.; Moraleda, José M.; Mateos, María-Victoria; Pascal, Mariona; Urbano Ispizua, Álvaro; Fernández de Larrea, Carlos |
| 27-Dec-2022 | Real-world effectiveness of caplacizumab vs the standard of care in immune thrombotic thrombocytopenic purpura | Pascual Izquierdo, Cristina; Mingot Castellano, María Eva; Kerguelen Fuentes, Ana E.; García Arroba Peinado, José; Cid Vidal, Joan; Jimenez, Maria Moraima; Valcarcel, David; Gómez Seguí, Inés; Rubia, Javier de la; Martin, Paz; Goterris, Rosa; Hernández, Luis; Tallón, Inmaculada; Varea, Sara; Fernández, Marta; García Muñoz, Nadia; Vara, Míriam; Fernández Zarzoso, Miguel; García Candel, Faustino; Paciello, María Liz; García García, Irene; Zalba, Saioa; Campuzano, Verónica; Gala, José María; Vidán Estévez, Julia; Moreno Jiménez, Gemma; López Lorenzo, José Luis; González Arias, Elena; Freiría, Carmen; Solé, María; Ávila Idrovo, Laura Francisca; Hernández Castellet, José Carlos; Cruz, Naylen; Lavilla, Esperanza; Pérez Montaña, Albert; Atucha, Jon Ander; Moreno Beltrán, María Esperanza; Moreno Macías, Juán Ramón; Salinas, Ramón; Rio Garma, Julio del; Spanish Apheresis Group (GEA); Spanish Thrombotic Thrombocytopenic Purpura Registry (REPTT) |
| 6-Feb-2012 | TET2 mutations are associated with specific 5-methylcytosine and 5-hydroxymethylcytosine profiles in patients with chronic myelomonocytic leukemia | Pérez, Cristina; Martínez-Calle, Nicolas; Martín-Subero, José Ignacio; Segura, Victor; Delabesse, Eric; Fernandez-Mercado, Marta; Garate, Leire; Alvarez, Sara; Rifón, José; Varea, Sara; Boultwood, Jacqueline; Wainscoat, James S.; Cigudosa, Juan Cruz; Calasanz, María José; Cross, Nicholas C.; Prósper, Felipe; Agirre, Xabier |